REFERENCES

• BushDE.ZiegelsteinRC.TaybackM.et al.Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.Am J Cardiol.20018833734111545750
   PubMed Web of Science ®Google Scholar
• BarefootJC.SchroIIM.Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.Circulation.199693197619808640971
   PubMed Web of Science ®Google Scholar
• PenninxBW.BeekmanAT.HonigA.et al.Depression and cardiac mortality: results from a community-based longitudinal study.Arch Gen Psychiatry.20015822122711231827
   PubMed Web of Science ®Google Scholar
• OhiraT.IsoH.SatohS.et al.Prospective study of depressive symptoms and risk of stroke among Japanese.Stroke.20013290390811283390
   PubMed Web of Science ®Google Scholar
• CarneyRM.FreedlandKE.RichMW.JaffeAS.Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms.Ann Behav Med.19951714214918425665
   PubMed Web of Science ®Google Scholar
• GlassmanAH.ShapiroPA.Depression and the course of coronary heart disease.Am J Psychiatry.1998155104111
   Web of Science ®Google Scholar
• CarneyRM.FreedlandKE.MillerGE.JaffeAS.Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms.J Psychosom Res.20025389790212377300
   PubMed Web of Science ®Google Scholar
• SchinsA.HamulyakK.ScharpeP.et al.Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.Life Sci.200424;76637650
   Web of Science ®Google Scholar
• AlvarezJC.GluckD.ArnulfI.et al.Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.Clin Pharmacol Ther.19996661762410613618
   PubMed Web of Science ®Google Scholar
• OwensMJ.NemeroffCB.Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.Clin Chem.1994402882957508830
   PubMed Web of Science ®Google Scholar
• GolinoP.PiscioneF.WillersonJT.et al.Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients.N Engl J Med.19913246416481994246
   PubMed Web of Science ®Google Scholar
• LiN.WallenNH.LadjevardiM.HjemdahlP.Effects of serotonin on platelet activation in whole blood.Blood Coagul Fibrinolysis.199785175239491270
   PubMed Web of Science ®Google Scholar
• SkopBP.BrownTM.Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.Psychosomatics.19963712168600488
   PubMed Web of Science ®Google Scholar
• TroyGC.An overview of hemostasis.Vet Clin North Am Small Anim Pract.1988185203282384
   PubMed Web of Science ®Google Scholar
• SchinsA.HonigA.CrijnsH.BaurL.HamulyakK.Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?Psychosom Med.20036572977714508013
   PubMed Web of Science ®Google Scholar
• PiletzJE.ZhuH.MadakasiraS.et al.Elevated P-Selectin on platelets in depression: response tobupropion. J Psych iatr Res.200034397404
   PubMed Web of Science ®Google Scholar
• MusselmanDL.TomerA.ManatungaAK.et al.Exaggerated platelet reactivity in major depression.Am J Psych ia try.199615313131317
   PubMed Web of Science ®Google Scholar
• Laghrissi-ThodeF.WagnerWR.PollockBG.JohnsonPC.FinkelMS.Elevated platelet factor 4 and p-thromboglobulin plasma levels in depressed patients with ischemic heart disease.Biol Psychiatry.1997422902959270907
   PubMed Web of Science ®Google Scholar
• NemeroffCB.MusselmanDL.Are platelets the link between depression and ischemic heart disease?Am Heart J.2000140 (4 suppl)576211011349
   PubMed Web of Science ®Google Scholar
• Leung LawrenceLK.Overview of hemostasis. Available at: www.uptodate.com Accessed November 2006
   Google Scholar
• ColmanRW.ClowesAW.GeorgeJN.et al.Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Fifth ed. Philadelphia, Pa: Lippincott Williams & Wilkins;2006
   Google Scholar
• De ClerckF.The role of serotonin in thrombogenesis.Clin Physiol Biochem.19908(suppl 3)40491966729
   PubMedGoogle Scholar
• ButlerJ.LeonardBE.The platelet serotonergic system in depression and following sertraline treatment.Int Clin Psychopharmacol.198833433473235819
   PubMed Web of Science ®Google Scholar
• MarkovitzJH.ShusterJL.ChitwoodWS.MayRS.TolbertLC.Platelet activation in depression and effects of sertraline treatment: an open-label study.Am J Psychiatry.20001571006100810831484
   PubMed Web of Science ®Google Scholar
• MusselmanDL.MarzecUM.ManatungaA.et al.Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.Arch Gen Psychiatry.20005787588210986551
   PubMed Web of Science ®Google Scholar
• MenysVC.SmithCC.LewinsP.FarmerRD.NobleMl.Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine.Clin Sci (Lond).9969187928774265
   PubMed Web of Science ®Google Scholar
• Laine-CessacP.ShoaayI.GarreJB.GlaudV.TurcantA.AllainP.Study of haemostasis in depressive patients treated with fluoxetine.Pharmacoepidemiol Drug Saf.19987(suppl 1)S54S5715073961
   PubMed Web of Science ®Google Scholar
• AldermanCP.SeshadriP.Ben-TovimDl.Effects of serotonin reuptake inhibitors on hemostasis.Ann Pharmacother.199630123212348913401
   PubMed Web of Science ®Google Scholar
• TharmapathyP.SelheimF.OdegaardK.LundA.HolmsenH.Venlafaxine treatment stimulates blood platelet activity.J Clin Psychopharmacol.20002058959011001252
   PubMed Web of Science ®Google Scholar
• Gomez-GilE.GastoC.CarreteroM.et al.Decrease of the platelet 5HT2A receptor function by long-term imipramine treatment in endogenous depression.Hum Psychopharmacol.20041925125815181653
   PubMed Web of Science ®Google Scholar
• LederbogenF.GillesM.MarasA.et al.Increased platelet aggregability in major depression?Psychiatry Res.20012425526111440776
   PubMedGoogle Scholar
• LederbogenF.WeberB.CollaM.HeuserH.DeuschleM.DempfleCE.Antidepressant treatment and global tests of coagulation and fibrinolysis.J Clin Psychiatry.2001622
   Web of Science ®Google Scholar
• BerkM.JacobsonBF.HurlyE.Fluoxetine and hemostatic function: a pilot study.J Clin Psychiatry.19955614167836333
   PubMed Web of Science ®Google Scholar
• BangNU.Acquired abnormalities of platelet function [letter].N Engl J Med.199132416722030725
   PubMedGoogle Scholar
• HergovichN.AignerM.EichlerHG.EntlicherJ.DruckerC.JilmaB.Paroxetine decreases platelet serotonin storage and platelet function in human beings.Clin Pharmacol Ther.20006843544211061584
   PubMed Web of Science ®Google Scholar
• SerebruanyVL.GlassmanAH.MalininAI.et al.Endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy.Circulation.200310893994412912814
   PubMed Web of Science ®Google Scholar
• PollockBG.Laghrissi-ThodeF.WagnerWR.Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.J Clin Psychopharmacol.20002013714010770450
   PubMed Web of Science ®Google Scholar
• MohammadSF.MasonRG.Inhibition of human platelet-collagen adhesion reaction by amitriptyline and impramine.Proc Soc Exp Biol Med.1974145110611134206514
   PubMed Web of Science ®Google Scholar
• SerebruanyVL.GurbelPA.O'ConnorCM.Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.Pharmacol Res.20014345346211394937
   PubMed Web of Science ®Google Scholar
• BondurantT.DarrellMJ.El AsyoutyS.et al.Effect of fluoxetine on prothrombin time.Psychosomatics.1998392962989664780
   PubMed Web of Science ®Google Scholar
• AldermanCP.MoritzCK.Ben-TovimDl.Abnormal platelet aggregation associated with fluoxetine therapy.Ann Pharmacother.199226151715191482806
   PubMed Web of Science ®Google Scholar
• De MaistreE.AllartC.LecompteT.BollaertPE.Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors.Am J Med.200211353053212427509
   PubMed Web of Science ®Google Scholar
• AranthJ.LindbergC.Bleeding, a side effect of fluoxetine.Am J Psychiatry.19921494121536285
   PubMed Web of Science ®Google Scholar
• LeungM.ShoreR.Fluvoxamine-associated bleeding.Can J Psychiatry.1996416046058946088
   PubMed Web of Science ®Google Scholar
• OttervangerJP.StriekerBH.HulsJ.WeedaJN.Bleeding attributed to the intake of paroxetine.Am J Psychiatry.19941517817828166328
   PubMed Web of Science ®Google Scholar
• EvansTG.BuysSS.RodgersGM.Acquired abnormalities of platelet function [letter].N Engl J Med.19913241671
   Web of Science ®Google Scholar
• HumphriesJE.WhebyMS.VandenbergSR.Fluoxetine and the bleeding time.Arch Pathol Lab Med.19901147277282363631
   PubMed Web of Science ®Google Scholar
• CalhounJW.CalhounDD.Prolonged bleeding time in a patient treated with sertraline.Am J Psychiatry.19961534438610842
   PubMed Web of Science ®Google Scholar
• CeylanME.Alpsan-OmayMH.Bleeding induced by SSRIs.Eur Psychiatry.20052057057116337893
   PubMed Web of Science ®Google Scholar
• ThamCJ.TrewM.BragerN.Abnormal clotting and production of factor VIII inhibitor in a patient treated with venlafaxine.Can J Psychiatry.19994492392410584166
   PubMed Web of Science ®Google Scholar
• DemetMM.MizrakS.Esen-DanaciA.Mirtazapine-induced arthralgia and coagulopathy: a case report.J Clin Psychopharmacol.20052539539616012290
   PubMed Web of Science ®Google Scholar
• HardyJL.SiroisA.Reduction of prothrombin and partial thromboplastin times with trazodone.CMAJ.1986 1513513723779574
   PubMed Web of Science ®Google Scholar
• TielensJA.Vitamin C for paroxetine - and fluvoxamine - associated bleeding.Am J Psychiatry.1997 1548838849167526
   PubMed Web of Science ®Google Scholar
• DaltonSO.JohansenC.MellemkjoerL.NorgardB.SorensenHT.OlsenJH.Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding.Arch Intern Med.2003163596412523917
   PubMed Web of Science ®Google Scholar
• de AbajoFJ.Garcia RodriguezLA.MonteraD.Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.BMJ.19993191106110910531103
   PubMed Web of Science ®Google Scholar
• van WalravenC.MamdaniMM.WellsPS.WilliamsJL.Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study.BMJ.20013231611440920
   PubMedGoogle Scholar
• PaiVB.KellyMW.Bruising associated with the use of fluoxetine.Ann Pharmacother.1996307867888826562
   PubMed Web of Science ®Google Scholar
• LaytonD.ClarkDW.PearceGL.ShakirSA.Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?Eur J Clin Pharmacol.20015716717611417450
   PubMed Web of Science ®Google Scholar
• MeijerWE.HeerdinkER.NolenWA.HeringsRM.LeufkensHG.EgbertsAC.Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.Arch Intern Med.20041642367237015557417
   PubMedGoogle Scholar
• MovigKL.JanssenMW.de Waal MalefijtJ.KabelPJ.LeufkensHG.EgbertsAC.Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.Arch Intern Med.20031632354235814581256
   PubMed Web of Science ®Google Scholar
• TataLJ.FortunPJ.HubbardRB.et al.Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?Aliment Pharmacol Ther.20052217518116091054
   PubMed Web of Science ®Google Scholar
• TatsumiM.GroshanK.BlakelyRD.RîchelsonE.Pharmacological profile of antidepressants and related compounds at human monoamine transporters.Eur J Pharmacol.19973402492589537821
   PubMed Web of Science ®Google Scholar
• RichelsonE.Pharmacology of antidepressants: clinical relevance of effects on neurotransmitter systems and their receptors. In: Den Boer JA, Westenberg HGM, eds.Antidepressants: Selectivity or Multiplicity. Amsterdam, the Netherlands: Benecke NI;20014360
   Google Scholar
• NelvaA.GuyC.Tardy-PoncetB.et al..Syndromes hémorragiques sous antidépresseurs inhibiteurs sélectifs de la recapture de la serotonine (ISRS). A propos de sept cas et revue de la littérature.Rev Méd Interne.200021152160
   PubMedGoogle Scholar
• VandelP.VandelS.KantelipJP.SSRI-induced bleeding: two case reports.Thérapie.200156445447
   PubMed Web of Science ®Google Scholar
• WilmhurstPT.KumarAV.Subhyaloid haemorrhage with fluoxetine.Eye.19961014150
   Web of Science ®Google Scholar
• GunzbergerDW.MartinezD.Adverse vascular effects associated with fluoxetine.Am J Psychiatry199214917511443256
   PubMed Web of Science ®Google Scholar
• Yaryura-TobiasJA.KirschenH.NimanP.MosbergHJ.Fluoxetine and bleeding in obsessive-compulsive disorder.Am J Psychiatry.19911489492053641
   PubMed Web of Science ®Google Scholar
• MhannaMJ.BennetJB.IzattSD.Potential fluoxetine chloride (Prozac) toxicity in a newborn.Pediatrics.19971001581599229710
   PubMed Web of Science ®Google Scholar
• SmithM.RobinsonD.Sertraline and vaginal bleeding: a possible association [letter].J Am Geriatr Soc.20025020020112028271
   PubMed Web of Science ®Google Scholar
• LakeMB.BirmaherB.WassickS.MathosK.YelovichAK.Bleeding and selective serotonine reuptake inhibitors in childhood and adolescence.J Child Adolesc Psychopharmacol.2000 10353810755580
   PubMed Web of Science ®Google Scholar
• ShenW.SwartzC.CalhounJ.Is inhibition of nitric oxide synthase a mechanism for SSRI-induced bleeding? [letter].Psychosomatics.19994026828910341542
   PubMed Web of Science ®Google Scholar
• HolzerL.HalfonO.Sertraline and gastrointestinal bleeding in an adolescent girl.J Child Adolesc Psychopharmacol.2006161216553521
   PubMed Web of Science ®Google Scholar
• CooperTA.ValcourVG.GibbonsRB.O'Brien-FallsK.Spontaneous ecchymoses due to paroxetine administration.Am J Med.19981041971989528740
   PubMed Web of Science ®Google Scholar
• DuijvestijnYC.KalmeijerMD.PassierAL.DahlemP.SmiersF.Neonatal intraventricular haemorrhage associated with maternal use of paroxetine.Br J Clin Pharmacol.20035658158214651736
   PubMed Web of Science ®Google Scholar
• BergC.CouturierF.GrassF.AujoulatO.GuillardD.StoeckelC.Saignements sous inhibiteurs spécifiques de la recapture de la sérotonine: à propos d'un cas clinique.Thérapie.2001566567
   PubMedGoogle Scholar
• KohnS.LabbateLA.Venlafaxine and ecchymoses.Can J Psychiatry.199742919040933
   PubMed Web of Science ®Google Scholar
• LinneburSA.SaseenJJ.PaceWD.Venlafaxine-associated vaginal bleeding.Pharmacotherapy.20022265265512013367
   PubMed Web of Science ®Google Scholar
• RubellEB.Does imipramine (Tofranil) cause oral bleeding?Pediatrics.1969431441455304344
   PubMed Web of Science ®Google Scholar
• BenazziF.Hemorrhages during escitalopram- venlafaxine-mirtazapine combination treatment of depression.Can J Psychiatry.20055018415830829
   PubMedGoogle Scholar
• DupontA.FontanaP.Bachelot-LozaC.et al.An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN.Blood.20031011833184012406873
   PubMed Web of Science ®Google Scholar
• SewnathME.van HillegersbergR.KoopmanMM.LeviMM.GoumaDJ.Increased perioperative blood loss during treatment with paroxetine.Ned Tijdschr Geneeskd.20021461800180212369443
   PubMedGoogle Scholar